Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2013 Jul 12;111(3):216–220. doi: 10.1016/j.anai.2013.06.008

Figure 1.

Figure 1

Relationship between both once daily ICS dosing (black bars) and ≥2 times daily ICS dosing (gray bars) and ICS adherence among patient subgroups defined by sex, race-ethnicity, age, and asthma severity. Adherence between once daily and ≥2 times daily ICS dosing was statistically significant for all subgroups analyzed (P<0.01).